| Callie Simoneaux Dorn, CRNA | |
|
7777 Hennessy Blvd, Suite 301, Baton Rouge, LA 70808-4300 | |
| (225) 214-6436 | |
| Not Available |
| Full Name | Callie Simoneaux Dorn |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 11 Years |
| Location | 7777 Hennessy Blvd, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043632235 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | AP07623 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baton Rouge General Medical Center | Baton rouge, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Diversified Professionals, Inc. | 0446356463 | 71 |
| The Capital City Anesthesia Group | 1658272844 | 45 |
News Archive
Forest Laboratories, Inc. today announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal and Cystic Fibrosis company, for $2.9 billion in cash from its shareholders, including TPG, the global private investment firm. The acquisition, which requires review by anti-trust authorities in the US and Canada, is expected to be accretive to Forest's FY2015 non-GAAP EPS.
Most patients in the southeastern United States are satisfied with the care they get from their primary care doctor — though many doctors lack training for dealing with patients of different ethnic backgrounds and often fail to ask important questions that indicate multicultural awareness, according to results of two surveys presented at the American Heart Association's 11th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
The SanBio Group announces today that the Phase 2 STEMTRA trial using SB623 cells for the treatment of patients with traumatic brain injury, met its primary endpoint.
Milk thistle extract, an herbal remedy since the times of the ancient Greeks and Romans, is today one of the most popular herbal supplements, with U.S. retail sales of nearly nine million dollars.
› Verified 3 days ago
| Entity Name | Anesthesiology Group Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255399598 PECOS PAC ID: 0042110298 Enrollment ID: O20040113000117 |
News Archive
Forest Laboratories, Inc. today announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal and Cystic Fibrosis company, for $2.9 billion in cash from its shareholders, including TPG, the global private investment firm. The acquisition, which requires review by anti-trust authorities in the US and Canada, is expected to be accretive to Forest's FY2015 non-GAAP EPS.
Most patients in the southeastern United States are satisfied with the care they get from their primary care doctor — though many doctors lack training for dealing with patients of different ethnic backgrounds and often fail to ask important questions that indicate multicultural awareness, according to results of two surveys presented at the American Heart Association's 11th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
The SanBio Group announces today that the Phase 2 STEMTRA trial using SB623 cells for the treatment of patients with traumatic brain injury, met its primary endpoint.
Milk thistle extract, an herbal remedy since the times of the ancient Greeks and Romans, is today one of the most popular herbal supplements, with U.S. retail sales of nearly nine million dollars.
› Verified 3 days ago
| Entity Name | The Capital City Anesthesia Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245282466 PECOS PAC ID: 1658272844 Enrollment ID: O20040120000494 |
News Archive
Forest Laboratories, Inc. today announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal and Cystic Fibrosis company, for $2.9 billion in cash from its shareholders, including TPG, the global private investment firm. The acquisition, which requires review by anti-trust authorities in the US and Canada, is expected to be accretive to Forest's FY2015 non-GAAP EPS.
Most patients in the southeastern United States are satisfied with the care they get from their primary care doctor — though many doctors lack training for dealing with patients of different ethnic backgrounds and often fail to ask important questions that indicate multicultural awareness, according to results of two surveys presented at the American Heart Association's 11th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
The SanBio Group announces today that the Phase 2 STEMTRA trial using SB623 cells for the treatment of patients with traumatic brain injury, met its primary endpoint.
Milk thistle extract, an herbal remedy since the times of the ancient Greeks and Romans, is today one of the most popular herbal supplements, with U.S. retail sales of nearly nine million dollars.
› Verified 3 days ago
| Entity Name | Diversified Professionals, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700923992 PECOS PAC ID: 0446356463 Enrollment ID: O20070507000647 |
News Archive
Forest Laboratories, Inc. today announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal and Cystic Fibrosis company, for $2.9 billion in cash from its shareholders, including TPG, the global private investment firm. The acquisition, which requires review by anti-trust authorities in the US and Canada, is expected to be accretive to Forest's FY2015 non-GAAP EPS.
Most patients in the southeastern United States are satisfied with the care they get from their primary care doctor — though many doctors lack training for dealing with patients of different ethnic backgrounds and often fail to ask important questions that indicate multicultural awareness, according to results of two surveys presented at the American Heart Association's 11th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
The SanBio Group announces today that the Phase 2 STEMTRA trial using SB623 cells for the treatment of patients with traumatic brain injury, met its primary endpoint.
Milk thistle extract, an herbal remedy since the times of the ancient Greeks and Romans, is today one of the most popular herbal supplements, with U.S. retail sales of nearly nine million dollars.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Callie Simoneaux Dorn, CRNA 7777 Hennessy Blvd, Suite 301, Baton Rouge, LA 70808-4300 Ph: (225) 214-6436 | Callie Simoneaux Dorn, CRNA 7777 Hennessy Blvd, Suite 301, Baton Rouge, LA 70808-4300 Ph: (225) 214-6436 |
News Archive
Forest Laboratories, Inc. today announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal and Cystic Fibrosis company, for $2.9 billion in cash from its shareholders, including TPG, the global private investment firm. The acquisition, which requires review by anti-trust authorities in the US and Canada, is expected to be accretive to Forest's FY2015 non-GAAP EPS.
Most patients in the southeastern United States are satisfied with the care they get from their primary care doctor — though many doctors lack training for dealing with patients of different ethnic backgrounds and often fail to ask important questions that indicate multicultural awareness, according to results of two surveys presented at the American Heart Association's 11th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
The SanBio Group announces today that the Phase 2 STEMTRA trial using SB623 cells for the treatment of patients with traumatic brain injury, met its primary endpoint.
Milk thistle extract, an herbal remedy since the times of the ancient Greeks and Romans, is today one of the most popular herbal supplements, with U.S. retail sales of nearly nine million dollars.
› Verified 3 days ago
Toni Tolar, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8325 Kelwood Ave, Baton Rouge, LA 70806 Phone: 225-929-7600 Fax: 225-930-7524 | |
Holli B Cordell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7145 Perkins Road, Baton Rouge, LA 70808 Phone: 225-769-4403 Fax: 225-769-4403 | |
Amy Johnson, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd, Suite 301, Baton Rouge, LA 70808 Phone: 225-214-6438 | |
Mrs. Courtney Day Passman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7145 Perkins Road, Baton Rouge, LA 70808 Phone: 225-765-3111 Fax: 225-765-3114 | |
Denise N Baumgartner, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 8212 Summa Ave, Baton Rouge, LA 70809 Phone: 225-769-4403 Fax: 225-769-3842 | |
Kaley Mcclure, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5000 Hennessy Blvd, Baton Rouge, LA 70808 Phone: 225-765-8541 | |
Alton J Ardoin, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 7855 Howell Blvd, Baton Rouge, LA 70807 Phone: 225-358-4900 |